Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SMAD4
|
ENSG00000141646.14 | SMAD4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SMAD4 | hg38_v1_chr18_+_51030100_51030270 | -0.75 | 1.7e-06 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_50953093 | 4.44 |
ENST00000593428.5
|
KLK5
|
kallikrein related peptidase 5 |
chrX_-_48470243 | 3.97 |
ENST00000429543.2
ENST00000620913.5 |
SLC38A5
|
solute carrier family 38 member 5 |
chrX_-_48470163 | 3.90 |
ENST00000595796.5
|
SLC38A5
|
solute carrier family 38 member 5 |
chr19_-_18941117 | 3.63 |
ENST00000600077.5
|
HOMER3
|
homer scaffold protein 3 |
chr22_+_31092447 | 3.38 |
ENST00000455608.5
|
SMTN
|
smoothelin |
chr19_-_50953063 | 3.09 |
ENST00000391809.6
|
KLK5
|
kallikrein related peptidase 5 |
chr9_+_128420812 | 3.09 |
ENST00000372838.9
|
CERCAM
|
cerebral endothelial cell adhesion molecule |
chr10_+_86958557 | 2.85 |
ENST00000372017.4
ENST00000348795.8 |
SNCG
|
synuclein gamma |
chr19_-_50952942 | 2.71 |
ENST00000594846.1
ENST00000336334.8 |
KLK5
|
kallikrein related peptidase 5 |
chr5_+_149141483 | 2.64 |
ENST00000326685.11
ENST00000309868.12 |
ABLIM3
|
actin binding LIM protein family member 3 |
chr1_-_24143112 | 2.59 |
ENST00000270800.2
|
IL22RA1
|
interleukin 22 receptor subunit alpha 1 |
chr19_+_41797147 | 2.56 |
ENST00000596544.1
|
CEACAM3
|
CEA cell adhesion molecule 3 |
chr2_-_112836702 | 2.52 |
ENST00000416750.1
ENST00000263341.7 ENST00000418817.5 |
IL1B
|
interleukin 1 beta |
chr5_+_149141817 | 2.52 |
ENST00000504238.5
|
ABLIM3
|
actin binding LIM protein family member 3 |
chr10_+_73911104 | 2.49 |
ENST00000446342.5
ENST00000372764.4 |
PLAU
|
plasminogen activator, urokinase |
chr9_-_21305313 | 2.46 |
ENST00000610521.2
|
IFNA5
|
interferon alpha 5 |
chr19_-_18941184 | 2.46 |
ENST00000594794.5
ENST00000392351.8 ENST00000596482.5 |
HOMER3
|
homer scaffold protein 3 |
chr5_-_39219555 | 2.34 |
ENST00000512982.4
ENST00000351578.12 ENST00000509072.5 ENST00000504542.1 ENST00000506557.5 |
FYB1
|
FYN binding protein 1 |
chr22_+_31082860 | 2.32 |
ENST00000619644.4
|
SMTN
|
smoothelin |
chr5_+_149141573 | 2.28 |
ENST00000506113.5
|
ABLIM3
|
actin binding LIM protein family member 3 |
chr1_+_152514474 | 2.22 |
ENST00000368790.4
|
CRCT1
|
cysteine rich C-terminal 1 |
chr19_-_48511793 | 2.15 |
ENST00000600059.6
|
LMTK3
|
lemur tyrosine kinase 3 |
chr1_-_28193873 | 2.13 |
ENST00000305392.3
ENST00000539896.1 |
PTAFR
|
platelet activating factor receptor |
chr11_-_107858777 | 2.10 |
ENST00000525815.6
|
SLC35F2
|
solute carrier family 35 member F2 |
chr20_-_44651683 | 2.08 |
ENST00000537820.1
ENST00000372874.9 |
ADA
|
adenosine deaminase |
chr22_+_30356620 | 2.08 |
ENST00000399824.6
ENST00000405659.5 |
CCDC157
|
coiled-coil domain containing 157 |
chr3_-_48595267 | 2.04 |
ENST00000328333.12
ENST00000681320.1 |
COL7A1
|
collagen type VII alpha 1 chain |
chr17_-_7394514 | 2.03 |
ENST00000571802.1
ENST00000619711.5 ENST00000576201.5 ENST00000573213.1 ENST00000324822.15 |
PLSCR3
|
phospholipid scramblase 3 |
chr12_-_54419259 | 1.98 |
ENST00000293379.9
|
ITGA5
|
integrin subunit alpha 5 |
chr17_-_7394240 | 1.98 |
ENST00000576362.5
ENST00000571078.5 |
PLSCR3
|
phospholipid scramblase 3 |
chr2_-_207165923 | 1.97 |
ENST00000309446.11
|
KLF7
|
Kruppel like factor 7 |
chr2_+_33134620 | 1.97 |
ENST00000402934.5
ENST00000404525.5 ENST00000407925.5 |
LTBP1
|
latent transforming growth factor beta binding protein 1 |
chr1_-_9129085 | 1.96 |
ENST00000377411.5
|
GPR157
|
G protein-coupled receptor 157 |
chr1_+_44746401 | 1.91 |
ENST00000372217.5
|
KIF2C
|
kinesin family member 2C |
chr20_-_23986795 | 1.87 |
ENST00000286890.8
ENST00000278765.8 |
GGTLC1
|
gamma-glutamyltransferase light chain 1 |
chr22_-_27801712 | 1.85 |
ENST00000302326.5
|
MN1
|
MN1 proto-oncogene, transcriptional regulator |
chr2_+_30231524 | 1.85 |
ENST00000395323.9
ENST00000406087.5 ENST00000404397.5 |
LBH
|
LBH regulator of WNT signaling pathway |
chr2_+_33134579 | 1.82 |
ENST00000418533.6
|
LTBP1
|
latent transforming growth factor beta binding protein 1 |
chr10_+_101131284 | 1.81 |
ENST00000370196.11
ENST00000467928.2 |
TLX1
|
T cell leukemia homeobox 1 |
chr1_+_20589044 | 1.80 |
ENST00000375071.4
|
CDA
|
cytidine deaminase |
chr11_-_61880463 | 1.79 |
ENST00000531956.5
|
FADS3
|
fatty acid desaturase 3 |
chr17_+_44004604 | 1.78 |
ENST00000293404.8
ENST00000589767.1 |
NAGS
|
N-acetylglutamate synthase |
chr2_-_227164194 | 1.76 |
ENST00000396625.5
|
COL4A4
|
collagen type IV alpha 4 chain |
chr22_-_18518161 | 1.75 |
ENST00000619998.1
|
GGTLC3
|
gamma-glutamyltransferase light chain family member 3 |
chr22_-_37484505 | 1.73 |
ENST00000442496.1
|
MFNG
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr17_+_76385256 | 1.71 |
ENST00000392496.3
|
SPHK1
|
sphingosine kinase 1 |
chr2_+_157257687 | 1.69 |
ENST00000259056.5
|
GALNT5
|
polypeptide N-acetylgalactosaminyltransferase 5 |
chr1_+_203626813 | 1.68 |
ENST00000357681.10
|
ATP2B4
|
ATPase plasma membrane Ca2+ transporting 4 |
chr1_+_203626775 | 1.68 |
ENST00000367218.7
|
ATP2B4
|
ATPase plasma membrane Ca2+ transporting 4 |
chrX_+_136197039 | 1.67 |
ENST00000370683.6
|
FHL1
|
four and a half LIM domains 1 |
chr1_+_109687834 | 1.61 |
ENST00000349334.7
ENST00000476065.6 ENST00000483399.6 ENST00000369819.2 |
GSTM1
|
glutathione S-transferase mu 1 |
chr15_-_89221558 | 1.61 |
ENST00000268125.10
|
RLBP1
|
retinaldehyde binding protein 1 |
chr4_-_110198650 | 1.58 |
ENST00000394607.7
|
ELOVL6
|
ELOVL fatty acid elongase 6 |
chr19_-_11577632 | 1.56 |
ENST00000590420.1
ENST00000648477.1 |
ACP5
|
acid phosphatase 5, tartrate resistant |
chr7_+_48089257 | 1.55 |
ENST00000436673.5
ENST00000395564.9 |
UPP1
|
uridine phosphorylase 1 |
chr15_+_67128103 | 1.53 |
ENST00000558894.5
|
SMAD3
|
SMAD family member 3 |
chr14_-_24263162 | 1.52 |
ENST00000206765.11
ENST00000544573.5 |
TGM1
|
transglutaminase 1 |
chr20_+_61599755 | 1.51 |
ENST00000543233.2
|
CDH4
|
cadherin 4 |
chr11_-_125592448 | 1.50 |
ENST00000648911.1
|
FEZ1
|
fasciculation and elongation protein zeta 1 |
chr19_-_48513161 | 1.50 |
ENST00000673139.1
|
LMTK3
|
lemur tyrosine kinase 3 |
chr2_-_9423444 | 1.50 |
ENST00000488451.5
ENST00000238091.8 ENST00000355346.9 |
ITGB1BP1
|
integrin subunit beta 1 binding protein 1 |
chr1_+_153416517 | 1.47 |
ENST00000368729.9
|
S100A7A
|
S100 calcium binding protein A7A |
chrX_+_136197020 | 1.46 |
ENST00000370676.7
|
FHL1
|
four and a half LIM domains 1 |
chr10_-_73433550 | 1.44 |
ENST00000299432.7
|
MSS51
|
MSS51 mitochondrial translational activator |
chrX_-_154374623 | 1.43 |
ENST00000369850.10
|
FLNA
|
filamin A |
chr1_-_27604176 | 1.41 |
ENST00000642416.1
|
AHDC1
|
AT-hook DNA binding motif containing 1 |
chr22_-_21225554 | 1.40 |
ENST00000405188.8
|
GGT2
|
gamma-glutamyltransferase 2 |
chr12_-_52814106 | 1.39 |
ENST00000551956.2
|
KRT4
|
keratin 4 |
chr14_+_64704380 | 1.38 |
ENST00000247226.13
ENST00000394691.7 |
PLEKHG3
|
pleckstrin homology and RhoGEF domain containing G3 |
chr9_+_109780292 | 1.37 |
ENST00000374530.7
|
PALM2AKAP2
|
PALM2 and AKAP2 fusion |
chr22_+_43923755 | 1.37 |
ENST00000423180.2
ENST00000216180.8 |
PNPLA3
|
patatin like phospholipase domain containing 3 |
chr6_-_111759053 | 1.36 |
ENST00000462856.6
ENST00000229471.8 |
FYN
|
FYN proto-oncogene, Src family tyrosine kinase |
chr19_-_42855691 | 1.36 |
ENST00000401467.6
|
PSG8
|
pregnancy specific beta-1-glycoprotein 8 |
chr22_-_24245059 | 1.36 |
ENST00000398292.3
ENST00000263112.11 ENST00000327365.10 ENST00000424217.1 |
GGT5
|
gamma-glutamyltransferase 5 |
chr22_-_37427433 | 1.35 |
ENST00000452946.1
ENST00000402918.7 |
ELFN2
ELFN2
|
extracellular leucine rich repeat and fibronectin type III domain containing 2 extracellular leucine rich repeat and fibronectin type III domain containing 2 |
chr1_-_27604135 | 1.35 |
ENST00000673934.1
ENST00000642245.1 |
AHDC1
|
AT-hook DNA binding motif containing 1 |
chr19_-_50514624 | 1.34 |
ENST00000601207.5
ENST00000598657.1 ENST00000376916.7 |
ASPDH
|
aspartate dehydrogenase domain containing |
chr5_+_151025343 | 1.34 |
ENST00000521632.1
|
GPX3
|
glutathione peroxidase 3 |
chr14_-_104978360 | 1.33 |
ENST00000333244.6
|
AHNAK2
|
AHNAK nucleoprotein 2 |
chr1_+_11691688 | 1.32 |
ENST00000294485.6
|
DRAXIN
|
dorsal inhibitory axon guidance protein |
chr5_-_151686908 | 1.32 |
ENST00000231061.9
|
SPARC
|
secreted protein acidic and cysteine rich |
chr9_-_120877167 | 1.31 |
ENST00000373896.8
ENST00000312189.10 |
PHF19
|
PHD finger protein 19 |
chr13_-_39603123 | 1.31 |
ENST00000379589.4
|
LHFPL6
|
LHFPL tetraspan subfamily member 6 |
chr9_+_137225166 | 1.31 |
ENST00000650725.2
|
CYSRT1
|
cysteine rich tail 1 |
chr12_+_75480745 | 1.30 |
ENST00000266659.8
|
GLIPR1
|
GLI pathogenesis related 1 |
chr14_-_91253925 | 1.30 |
ENST00000531499.2
|
GPR68
|
G protein-coupled receptor 68 |
chr11_+_117199363 | 1.30 |
ENST00000392951.9
ENST00000525531.5 ENST00000278968.10 |
TAGLN
|
transgelin |
chr12_+_75480800 | 1.28 |
ENST00000456650.7
|
GLIPR1
|
GLI pathogenesis related 1 |
chr20_+_44337043 | 1.28 |
ENST00000217043.4
|
R3HDML
|
R3H domain containing like |
chr6_-_35688907 | 1.28 |
ENST00000539068.5
ENST00000357266.9 |
FKBP5
|
FKBP prolyl isomerase 5 |
chr2_-_42764116 | 1.27 |
ENST00000378661.3
|
OXER1
|
oxoeicosanoid receptor 1 |
chr1_+_109687789 | 1.27 |
ENST00000309851.10
ENST00000369823.6 |
GSTM1
|
glutathione S-transferase mu 1 |
chr20_+_32010429 | 1.26 |
ENST00000452892.3
ENST00000262659.12 |
CCM2L
|
CCM2 like scaffold protein |
chr3_-_48556785 | 1.25 |
ENST00000232375.8
ENST00000383734.6 ENST00000416568.5 ENST00000412035.5 |
PFKFB4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
chr2_+_101839815 | 1.25 |
ENST00000421882.5
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4 |
chr11_+_35189964 | 1.22 |
ENST00000524922.1
|
CD44
|
CD44 molecule (Indian blood group) |
chr1_-_28176665 | 1.22 |
ENST00000373857.8
|
PTAFR
|
platelet activating factor receptor |
chr20_-_35292415 | 1.21 |
ENST00000374408.4
|
FAM83C
|
family with sequence similarity 83 member C |
chr15_+_40161003 | 1.21 |
ENST00000412359.7
ENST00000287598.11 |
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B |
chr15_+_80779343 | 1.20 |
ENST00000220244.7
ENST00000394685.8 ENST00000356249.9 |
CEMIP
|
cell migration inducing hyaluronidase 1 |
chr12_+_75481204 | 1.19 |
ENST00000550491.1
|
GLIPR1
|
GLI pathogenesis related 1 |
chr7_+_134866831 | 1.19 |
ENST00000435928.1
|
CALD1
|
caldesmon 1 |
chr12_-_48971680 | 1.19 |
ENST00000403957.5
|
WNT10B
|
Wnt family member 10B |
chr17_+_43398984 | 1.18 |
ENST00000320033.5
|
ARL4D
|
ADP ribosylation factor like GTPase 4D |
chr16_+_66604696 | 1.17 |
ENST00000567572.6
ENST00000564060.5 ENST00000565922.1 |
CMTM3
|
CKLF like MARVEL transmembrane domain containing 3 |
chr10_+_80132722 | 1.16 |
ENST00000372263.4
|
PLAC9
|
placenta associated 9 |
chr19_-_42528380 | 1.16 |
ENST00000403461.5
ENST00000352591.9 ENST00000358394.7 ENST00000403444.7 ENST00000161559.11 ENST00000599389.1 |
CEACAM1
|
CEA cell adhesion molecule 1 |
chr12_-_48971723 | 1.15 |
ENST00000301061.9
|
WNT10B
|
Wnt family member 10B |
chr16_+_68843515 | 1.14 |
ENST00000261778.2
|
TANGO6
|
transport and golgi organization 6 homolog |
chr11_+_35189869 | 1.14 |
ENST00000525688.5
ENST00000278385.10 ENST00000533222.5 |
CD44
|
CD44 molecule (Indian blood group) |
chr22_+_22646310 | 1.12 |
ENST00000417145.2
|
GGTLC2
|
gamma-glutamyltransferase light chain 2 |
chr22_+_37051731 | 1.12 |
ENST00000610767.4
ENST00000402077.7 ENST00000403888.7 |
KCTD17
|
potassium channel tetramerization domain containing 17 |
chr3_+_50279080 | 1.12 |
ENST00000316436.4
|
LSMEM2
|
leucine rich single-pass membrane protein 2 |
chr15_-_21742799 | 1.11 |
ENST00000622410.2
|
ENSG00000278263.2
|
novel protein, identical to IGHV4-4 |
chr19_-_49362376 | 1.10 |
ENST00000601519.5
ENST00000593945.6 ENST00000539846.5 ENST00000596757.1 ENST00000311227.6 |
TEAD2
|
TEA domain transcription factor 2 |
chr22_+_36253071 | 1.10 |
ENST00000422706.5
ENST00000426053.5 ENST00000319136.8 |
APOL1
|
apolipoprotein L1 |
chr6_+_12290353 | 1.09 |
ENST00000379375.6
|
EDN1
|
endothelin 1 |
chr4_+_155667096 | 1.09 |
ENST00000393832.7
|
GUCY1A1
|
guanylate cyclase 1 soluble subunit alpha 1 |
chr15_-_83284645 | 1.08 |
ENST00000345382.7
|
BNC1
|
basonuclin 1 |
chr4_+_155666827 | 1.07 |
ENST00000511507.5
ENST00000506455.6 |
GUCY1A1
|
guanylate cyclase 1 soluble subunit alpha 1 |
chr19_-_41353904 | 1.07 |
ENST00000221930.6
|
TGFB1
|
transforming growth factor beta 1 |
chr4_+_155666963 | 1.06 |
ENST00000455639.6
|
GUCY1A1
|
guanylate cyclase 1 soluble subunit alpha 1 |
chr2_+_113059194 | 1.06 |
ENST00000393200.7
|
IL36RN
|
interleukin 36 receptor antagonist |
chr1_+_155208727 | 1.05 |
ENST00000316721.8
|
MTX1
|
metaxin 1 |
chr17_-_41624541 | 1.05 |
ENST00000540235.5
ENST00000311208.13 |
KRT17
|
keratin 17 |
chr20_+_44355692 | 1.04 |
ENST00000316673.8
ENST00000609795.5 ENST00000457232.5 ENST00000609262.5 |
HNF4A
|
hepatocyte nuclear factor 4 alpha |
chr18_-_35497591 | 1.04 |
ENST00000589273.1
ENST00000586489.5 |
INO80C
|
INO80 complex subunit C |
chr22_-_29838227 | 1.03 |
ENST00000307790.8
ENST00000397771.6 ENST00000542393.5 |
ASCC2
|
activating signal cointegrator 1 complex subunit 2 |
chr11_+_847197 | 1.03 |
ENST00000532375.5
ENST00000346501.8 |
TSPAN4
|
tetraspanin 4 |
chr1_+_155208690 | 1.02 |
ENST00000368376.8
|
MTX1
|
metaxin 1 |
chr6_-_47042260 | 1.02 |
ENST00000371243.2
|
ADGRF1
|
adhesion G protein-coupled receptor F1 |
chr22_+_36253124 | 1.02 |
ENST00000438034.5
ENST00000427990.5 ENST00000397278.8 ENST00000397279.8 ENST00000433768.5 |
APOL1
|
apolipoprotein L1 |
chr1_+_183186238 | 1.02 |
ENST00000493293.5
ENST00000264144.5 |
LAMC2
|
laminin subunit gamma 2 |
chr4_+_153152163 | 1.02 |
ENST00000676423.1
ENST00000675745.1 ENST00000676348.1 ENST00000676408.1 ENST00000674874.1 ENST00000675315.1 ENST00000675518.1 |
TRIM2
ENSG00000288637.1
|
tripartite motif containing 2 novel protein |
chrX_-_48958348 | 1.02 |
ENST00000428668.2
|
OTUD5
|
OTU deubiquitinase 5 |
chr22_+_37051787 | 1.01 |
ENST00000456470.1
|
KCTD17
|
potassium channel tetramerization domain containing 17 |
chr2_-_70835808 | 1.01 |
ENST00000410009.5
|
CD207
|
CD207 molecule |
chr11_+_57598184 | 1.01 |
ENST00000677625.1
ENST00000676670.1 |
SERPING1
|
serpin family G member 1 |
chr19_-_49361475 | 1.00 |
ENST00000598810.5
|
TEAD2
|
TEA domain transcription factor 2 |
chr15_-_74203172 | 1.00 |
ENST00000616000.4
|
STRA6
|
signaling receptor and transporter of retinol STRA6 |
chr12_-_98644733 | 0.99 |
ENST00000299157.5
ENST00000393042.3 |
IKBIP
|
IKBKB interacting protein |
chr17_-_78874140 | 0.98 |
ENST00000585421.5
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
chr7_-_76618300 | 0.98 |
ENST00000441393.1
|
POMZP3
|
POM121 and ZP3 fusion |
chrX_-_15664798 | 0.98 |
ENST00000380342.4
|
CLTRN
|
collectrin, amino acid transport regulator |
chr2_+_173354820 | 0.97 |
ENST00000347703.7
ENST00000410101.7 ENST00000410019.3 ENST00000306721.8 |
CDCA7
|
cell division cycle associated 7 |
chr1_+_156284299 | 0.97 |
ENST00000456810.1
ENST00000405535.3 |
TMEM79
|
transmembrane protein 79 |
chr5_-_142686079 | 0.97 |
ENST00000337706.7
|
FGF1
|
fibroblast growth factor 1 |
chr6_-_130970428 | 0.97 |
ENST00000529208.5
|
EPB41L2
|
erythrocyte membrane protein band 4.1 like 2 |
chr7_+_142384328 | 0.96 |
ENST00000390361.3
|
TRBV7-3
|
T cell receptor beta variable 7-3 |
chr16_+_3020359 | 0.96 |
ENST00000341627.5
ENST00000326577.9 ENST00000575124.1 ENST00000575836.1 |
TNFRSF12A
|
TNF receptor superfamily member 12A |
chr13_+_30735523 | 0.96 |
ENST00000380490.5
|
ALOX5AP
|
arachidonate 5-lipoxygenase activating protein |
chr9_+_34990250 | 0.95 |
ENST00000454002.6
ENST00000545841.5 |
DNAJB5
|
DnaJ heat shock protein family (Hsp40) member B5 |
chr11_+_43942627 | 0.95 |
ENST00000617612.3
|
C11orf96
|
chromosome 11 open reading frame 96 |
chr17_-_78874038 | 0.95 |
ENST00000586057.5
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
chr1_-_47190013 | 0.95 |
ENST00000294338.7
|
PDZK1IP1
|
PDZK1 interacting protein 1 |
chr4_+_155667198 | 0.95 |
ENST00000296518.11
|
GUCY1A1
|
guanylate cyclase 1 soluble subunit alpha 1 |
chr5_+_177357834 | 0.95 |
ENST00000408923.8
|
RGS14
|
regulator of G protein signaling 14 |
chr11_-_60855943 | 0.95 |
ENST00000332539.5
|
PTGDR2
|
prostaglandin D2 receptor 2 |
chr3_+_155080088 | 0.95 |
ENST00000462745.5
|
MME
|
membrane metalloendopeptidase |
chr1_+_206865620 | 0.94 |
ENST00000367098.6
|
IL20
|
interleukin 20 |
chr20_+_33031648 | 0.94 |
ENST00000349552.1
|
BPIFB6
|
BPI fold containing family B member 6 |
chr17_-_41481140 | 0.93 |
ENST00000246639.6
ENST00000393989.1 |
KRT35
|
keratin 35 |
chr17_+_74215616 | 0.93 |
ENST00000529107.5
|
TTYH2
|
tweety family member 2 |
chr3_+_111999326 | 0.92 |
ENST00000494932.1
|
TAGLN3
|
transgelin 3 |
chr6_-_127459364 | 0.92 |
ENST00000487331.2
ENST00000483725.8 |
KIAA0408
|
KIAA0408 |
chr6_-_26285526 | 0.92 |
ENST00000377727.2
|
H4C8
|
H4 clustered histone 8 |
chr7_+_134565098 | 0.91 |
ENST00000652743.1
|
AKR1B15
|
aldo-keto reductase family 1 member B15 |
chr14_+_93927259 | 0.91 |
ENST00000556222.1
ENST00000554404.1 |
FAM181A
|
family with sequence similarity 181 member A |
chr20_-_45124463 | 0.91 |
ENST00000372785.3
|
WFDC12
|
WAP four-disulfide core domain 12 |
chr15_-_74433942 | 0.91 |
ENST00000543145.6
ENST00000261918.9 |
SEMA7A
|
semaphorin 7A (John Milton Hagen blood group) |
chr3_-_39154558 | 0.91 |
ENST00000514182.1
|
CSRNP1
|
cysteine and serine rich nuclear protein 1 |
chr15_-_83283449 | 0.90 |
ENST00000569704.2
|
BNC1
|
basonuclin 1 |
chr3_+_133746385 | 0.90 |
ENST00000482271.5
ENST00000402696.9 |
TF
|
transferrin |
chr14_+_24070837 | 0.89 |
ENST00000537691.5
ENST00000397016.6 ENST00000560356.5 ENST00000558450.5 |
CPNE6
|
copine 6 |
chrX_-_43882411 | 0.89 |
ENST00000378069.5
|
MAOB
|
monoamine oxidase B |
chrX_-_111270474 | 0.89 |
ENST00000324068.2
|
CAPN6
|
calpain 6 |
chr6_+_25726767 | 0.88 |
ENST00000274764.5
|
H2BC1
|
H2B clustered histone 1 |
chr7_-_107803215 | 0.87 |
ENST00000340010.10
ENST00000453332.1 |
SLC26A3
|
solute carrier family 26 member 3 |
chr11_+_65833944 | 0.87 |
ENST00000308342.7
|
SNX32
|
sorting nexin 32 |
chr22_+_30356974 | 0.87 |
ENST00000445005.5
ENST00000430839.5 ENST00000338306.8 |
CCDC157
|
coiled-coil domain containing 157 |
chr14_+_103100328 | 0.86 |
ENST00000559116.1
|
EXOC3L4
|
exocyst complex component 3 like 4 |
chr19_+_54415427 | 0.86 |
ENST00000301194.8
ENST00000376530.8 ENST00000445095.5 ENST00000376531.3 |
TTYH1
|
tweety family member 1 |
chr13_-_78603539 | 0.86 |
ENST00000377208.7
|
POU4F1
|
POU class 4 homeobox 1 |
chr8_+_103371490 | 0.85 |
ENST00000330295.10
ENST00000415886.2 |
CTHRC1
|
collagen triple helix repeat containing 1 |
chr7_+_86644829 | 0.85 |
ENST00000439827.1
ENST00000421579.1 |
GRM3
|
glutamate metabotropic receptor 3 |
chr19_-_55149193 | 0.85 |
ENST00000587758.5
ENST00000588981.6 ENST00000356783.9 ENST00000291901.12 ENST00000588426.5 ENST00000536926.5 ENST00000588147.5 |
TNNT1
|
troponin T1, slow skeletal type |
chr19_-_43781249 | 0.85 |
ENST00000615047.4
|
KCNN4
|
potassium calcium-activated channel subfamily N member 4 |
chr19_-_50513870 | 0.85 |
ENST00000389208.9
|
ASPDH
|
aspartate dehydrogenase domain containing |
chr2_-_27495185 | 0.84 |
ENST00000264703.4
|
FNDC4
|
fibronectin type III domain containing 4 |
chr20_-_57690624 | 0.84 |
ENST00000414037.5
|
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
chr7_+_154305256 | 0.83 |
ENST00000619756.4
|
DPP6
|
dipeptidyl peptidase like 6 |
chr18_+_21363593 | 0.83 |
ENST00000580732.6
|
GREB1L
|
GREB1 like retinoic acid receptor coactivator |
chr3_-_195892706 | 0.83 |
ENST00000673038.1
ENST00000678220.1 ENST00000428187.7 |
TNK2
|
tyrosine kinase non receptor 2 |
chr2_-_9423190 | 0.83 |
ENST00000497105.1
ENST00000360635.7 ENST00000359712.7 |
ITGB1BP1
|
integrin subunit beta 1 binding protein 1 |
chr1_+_226223618 | 0.82 |
ENST00000542034.5
ENST00000366810.6 |
MIXL1
|
Mix paired-like homeobox |
chr9_+_110048598 | 0.82 |
ENST00000434623.6
ENST00000374525.5 |
PALM2AKAP2
|
PALM2 and AKAP2 fusion |
chr11_-_111923722 | 0.82 |
ENST00000527950.5
|
CRYAB
|
crystallin alpha B |
chr11_-_72674394 | 0.81 |
ENST00000418754.6
ENST00000334456.10 ENST00000542969.2 |
PDE2A
|
phosphodiesterase 2A |
chr7_+_142332182 | 0.81 |
ENST00000547918.2
|
TRBV7-1
|
T cell receptor beta variable 7-1 (non-functional) |
chr9_+_34652167 | 0.81 |
ENST00000441545.7
ENST00000553620.5 |
IL11RA
|
interleukin 11 receptor subunit alpha |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 10.2 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
1.1 | 3.4 | GO:0098736 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.8 | 2.5 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.8 | 2.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.8 | 2.3 | GO:0071464 | cellular response to hydrostatic pressure(GO:0071464) |
0.7 | 2.2 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.7 | 2.9 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.7 | 2.1 | GO:0046108 | uridine metabolic process(GO:0046108) |
0.7 | 2.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) xanthine metabolic process(GO:0046110) |
0.7 | 3.3 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.6 | 1.8 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.6 | 1.7 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.5 | 8.0 | GO:0015816 | glycine transport(GO:0015816) |
0.5 | 4.0 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.5 | 1.4 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.5 | 0.5 | GO:0002784 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.4 | 2.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.4 | 7.9 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.4 | 0.9 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.4 | 1.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 0.8 | GO:0001300 | chronological cell aging(GO:0001300) |
0.4 | 1.7 | GO:0042335 | cuticle development(GO:0042335) |
0.4 | 1.2 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
0.4 | 1.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.4 | 1.8 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.4 | 0.4 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.4 | 1.1 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.4 | 2.5 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.4 | 1.1 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.3 | 1.0 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.3 | 1.9 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.3 | 1.3 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.3 | 1.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 2.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 1.7 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.3 | 8.0 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.3 | 0.8 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.3 | 1.3 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.3 | 1.5 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.3 | 5.6 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.2 | 1.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.2 | 1.5 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 2.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 0.7 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.2 | 1.0 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.2 | 0.7 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.2 | 0.9 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.2 | 0.7 | GO:2000452 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.2 | 1.9 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.7 | GO:0010193 | response to ozone(GO:0010193) |
0.2 | 0.7 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.2 | 0.7 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) sebum secreting cell proliferation(GO:1990654) |
0.2 | 1.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.6 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
0.2 | 1.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.2 | 1.5 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.2 | 0.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.6 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.2 | 1.2 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.2 | 0.6 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 0.6 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.2 | 0.8 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.2 | 1.3 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.2 | 0.6 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
0.2 | 1.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.2 | 1.1 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.2 | 0.5 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.2 | 0.5 | GO:0071529 | cementum mineralization(GO:0071529) |
0.2 | 0.5 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
0.2 | 0.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.7 | GO:0006311 | meiotic gene conversion(GO:0006311) |
0.2 | 0.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.2 | 0.5 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.2 | 2.0 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.2 | 0.3 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
0.2 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 1.0 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.2 | 1.0 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.2 | 0.3 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.2 | 0.5 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
0.2 | 1.8 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.2 | 1.2 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.2 | 0.7 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.2 | 1.0 | GO:0035803 | egg coat formation(GO:0035803) |
0.2 | 0.8 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 0.6 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.2 | 1.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 3.7 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 1.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.2 | 0.9 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.2 | 0.6 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.9 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.1 | 1.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 1.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.7 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 1.6 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.4 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.1 | 0.4 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.1 | 0.8 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 2.2 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 0.8 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.7 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 1.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.4 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.1 | 0.5 | GO:1902164 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) platelet alpha granule organization(GO:0070889) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.1 | 0.4 | GO:0031394 | maternal aggressive behavior(GO:0002125) positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.8 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 1.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.7 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 1.0 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 1.6 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.1 | 1.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 1.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 1.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.2 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.1 | 0.6 | GO:0051935 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.1 | 0.4 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
0.1 | 0.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 1.4 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.7 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.1 | 0.4 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.1 | 0.3 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
0.1 | 1.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 1.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 1.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 1.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 1.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 1.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 1.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.4 | GO:0019082 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.1 | 2.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.3 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.1 | 0.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 1.2 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.1 | 0.6 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.1 | 0.1 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.1 | 0.6 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 2.1 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 1.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 1.4 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 2.0 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.6 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.1 | 1.1 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.1 | 0.2 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 0.6 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
0.1 | 0.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
0.1 | 0.5 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.1 | 2.5 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.4 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.4 | GO:1990168 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.3 | GO:0048058 | compound eye corneal lens development(GO:0048058) |
0.1 | 0.9 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.8 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.8 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.7 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.1 | 0.7 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.6 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 1.0 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.1 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
0.1 | 0.4 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.1 | 0.8 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.1 | 1.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 1.0 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 2.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.4 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 1.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.5 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 3.5 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.4 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.1 | 0.4 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.2 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 0.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.2 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.1 | 1.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.7 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.6 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.1 | 0.4 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.2 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.1 | 0.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.3 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.2 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 0.2 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.1 | 0.8 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.2 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.1 | 0.1 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
0.1 | 0.5 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.1 | 0.7 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.6 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.6 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.1 | 0.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.2 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.1 | 0.1 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.1 | 0.5 | GO:0042262 | DNA protection(GO:0042262) |
0.1 | 0.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.2 | GO:0030047 | actin modification(GO:0030047) |
0.1 | 2.6 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.1 | 0.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.2 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 0.2 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
0.1 | 0.2 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.1 | 0.5 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.1 | 8.5 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.2 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.1 | 0.6 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.6 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 1.0 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 0.3 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.1 | 0.3 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.1 | 0.9 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 0.6 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 1.2 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.9 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 1.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.4 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.1 | 0.4 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.1 | 0.6 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 0.2 | GO:0072717 | transcription factor catabolic process(GO:0036369) cellular response to actinomycin D(GO:0072717) |
0.1 | 0.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.1 | 0.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 0.3 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.1 | 0.4 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
0.0 | 0.1 | GO:0006212 | uracil catabolic process(GO:0006212) uracil metabolic process(GO:0019860) |
0.0 | 0.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.2 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 1.6 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 1.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.0 | 0.4 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.0 | 0.6 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 1.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.3 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.0 | 0.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 2.2 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.3 | GO:0035524 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
0.0 | 0.3 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 0.7 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 1.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.2 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.0 | 5.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.8 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.2 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.0 | 1.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.8 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) |
0.0 | 0.7 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.3 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 1.8 | GO:0060324 | face development(GO:0060324) |
0.0 | 0.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.4 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.5 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.0 | 0.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.2 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.0 | 0.5 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.0 | 0.9 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.0 | 0.9 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.4 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.0 | 0.2 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.0 | 0.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 0.5 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 0.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 1.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.0 | 0.1 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 1.5 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.7 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 2.6 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.0 | 0.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.0 | 0.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.0 | 0.1 | GO:0050758 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
0.0 | 0.6 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.0 | 0.6 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.7 | GO:0051412 | response to corticosterone(GO:0051412) |
0.0 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.2 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.0 | 0.0 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.0 | 0.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.1 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.0 | 0.4 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.1 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.0 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.0 | 0.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 2.3 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.4 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.0 | 0.6 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.4 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.3 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.1 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 0.1 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.0 | 1.2 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 1.2 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.0 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 2.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.6 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.0 | 0.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.4 | GO:0060732 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 1.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 1.4 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.2 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 1.2 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 3.2 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.0 | 0.8 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 1.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.1 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.4 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.4 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.0 | 0.1 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.3 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.0 | 0.1 | GO:1901874 | negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.3 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.2 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.7 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 1.0 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.4 | GO:1904261 | positive regulation of extracellular matrix assembly(GO:1901203) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.0 | 0.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0060459 | left lung development(GO:0060459) |
0.0 | 0.8 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.5 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.0 | 0.7 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.4 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.2 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.0 | 0.1 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.0 | 0.4 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.6 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.0 | 2.1 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.0 | 0.6 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.4 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 1.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 1.4 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.0 | 1.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.4 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 1.4 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.0 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
0.0 | 0.2 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.0 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.9 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.1 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.6 | GO:0033574 | response to testosterone(GO:0033574) |
0.0 | 0.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.3 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.1 | GO:0032264 | IMP salvage(GO:0032264) |
0.0 | 0.5 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.1 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.0 | 0.4 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.3 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.2 | GO:0035909 | aorta morphogenesis(GO:0035909) |
0.0 | 0.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.6 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.0 | 0.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.0 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.0 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.1 | GO:0090385 | regulation of lysosomal lumen pH(GO:0035751) phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.8 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.0 | 0.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.4 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.0 | 0.3 | GO:2000816 | negative regulation of mitotic sister chromatid separation(GO:2000816) |
0.0 | 0.1 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.0 | 0.3 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 1.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.1 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.0 | 0.8 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.2 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.9 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.0 | 0.5 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.0 | 0.3 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.1 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.0 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.5 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.2 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 10.7 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.7 | 2.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.5 | 1.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.5 | 2.1 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.4 | 1.2 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.3 | 2.0 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.3 | 1.4 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 0.8 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.2 | 1.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.2 | 2.4 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.2 | 1.8 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.2 | 0.7 | GO:1990032 | parallel fiber(GO:1990032) |
0.2 | 0.7 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 1.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 0.7 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.2 | 3.9 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 0.8 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.2 | 0.8 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 1.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 1.1 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 2.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.4 | GO:0097679 | other organism cytoplasm(GO:0097679) |
0.1 | 0.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.4 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.1 | 0.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.1 | 2.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.1 | 0.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.9 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 1.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.4 | GO:1990879 | CST complex(GO:1990879) |
0.1 | 1.0 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.7 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.6 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 0.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 1.0 | GO:0043256 | laminin complex(GO:0043256) |
0.1 | 9.5 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 1.2 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.2 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.1 | 0.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 0.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.8 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 2.9 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 1.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.1 | 0.2 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 0.9 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.1 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 5.6 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 1.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.9 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 6.1 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.3 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.1 | 1.4 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.1 | 1.3 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 4.2 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.3 | GO:0034448 | EGO complex(GO:0034448) |
0.0 | 0.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.2 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.4 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 6.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 2.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.1 | GO:1990742 | microvesicle(GO:1990742) |
0.0 | 0.6 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 0.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.1 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.0 | 0.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 2.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.8 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.3 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 3.0 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 1.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.3 | GO:0070449 | elongin complex(GO:0070449) |
0.0 | 0.8 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 5.4 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 3.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 2.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.4 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 1.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.9 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 2.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 3.5 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.9 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 2.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 8.9 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 0.2 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.3 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.0 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.4 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.1 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.0 | 0.1 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.0 | 10.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.0 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.0 | 1.3 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.4 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.0 | GO:0031906 | late endosome lumen(GO:0031906) |
0.0 | 2.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 1.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.3 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 1.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 5.7 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 2.4 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.0 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.0 | 1.1 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.0 | 1.7 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.4 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.9 | 3.8 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.9 | 4.3 | GO:0050436 | microfibril binding(GO:0050436) |
0.7 | 2.1 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.7 | 8.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.6 | 1.7 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.5 | 2.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.4 | 7.9 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.4 | 1.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 7.5 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.4 | 1.1 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.4 | 1.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 0.9 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.3 | 2.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 1.2 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.3 | 4.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.3 | 2.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.3 | 1.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.3 | 1.1 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
0.3 | 1.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 1.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.3 | 1.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 3.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 0.7 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.2 | 1.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 2.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 1.1 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.2 | 0.6 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.2 | 0.9 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.2 | 1.1 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 1.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.2 | 0.6 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.2 | 1.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.2 | 0.6 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.2 | 2.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 1.4 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.2 | 0.8 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 1.0 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.2 | 0.8 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.2 | 0.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 1.1 | GO:0042835 | BRE binding(GO:0042835) |
0.2 | 0.7 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.2 | 1.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 1.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) nerve growth factor receptor activity(GO:0010465) |
0.2 | 0.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 3.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 2.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 2.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 1.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 0.6 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.2 | 0.5 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.2 | 2.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 1.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 3.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 2.9 | GO:0043295 | glutathione binding(GO:0043295) |
0.2 | 0.6 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.1 | 1.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 1.6 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 2.1 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.6 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.1 | 0.5 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.5 | GO:0043273 | CTPase activity(GO:0043273) |
0.1 | 0.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 1.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.9 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.1 | 1.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.5 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.1 | 1.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.4 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.1 | 2.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.3 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) cholestenol delta-isomerase activity(GO:0047750) |
0.1 | 0.3 | GO:0004914 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
0.1 | 1.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 2.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 1.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.7 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.4 | GO:0070026 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitric oxide binding(GO:0070026) nitrite reductase activity(GO:0098809) |
0.1 | 0.4 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 0.8 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.1 | 0.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.3 | GO:0044714 | GTP diphosphatase activity(GO:0036219) 2-hydroxy-adenosine triphosphate pyrophosphatase activity(GO:0044713) 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity(GO:0044714) ATP diphosphatase activity(GO:0047693) |
0.1 | 1.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.3 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 0.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.3 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.1 | 0.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 2.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.6 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.1 | 1.0 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.7 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 3.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 1.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.5 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 0.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.4 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.1 | 0.3 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
0.1 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.2 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 0.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 1.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 1.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 2.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 1.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.4 | GO:0043208 | fucose binding(GO:0042806) glycosphingolipid binding(GO:0043208) |
0.1 | 1.0 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.8 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) TPR domain binding(GO:0030911) |
0.1 | 1.2 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 1.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 1.4 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.4 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.1 | 1.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.6 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.9 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.2 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.1 | 0.2 | GO:0051990 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 6.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 1.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 1.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 1.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 2.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.2 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.0 | 0.3 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.0 | 0.3 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.0 | 0.2 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.3 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 1.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.4 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 1.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.4 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
0.0 | 1.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 1.2 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 13.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.3 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 0.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.0 | 0.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.6 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0017129 | triglyceride binding(GO:0017129) |
0.0 | 1.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.1 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.0 | 0.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 1.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 1.5 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 4.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 1.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 2.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.0 | 0.6 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.3 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.0 | 1.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 1.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.8 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.3 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.6 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 3.2 | GO:0008238 | exopeptidase activity(GO:0008238) |
0.0 | 0.1 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.0 | 0.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 1.0 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 2.1 | GO:0050661 | NADP binding(GO:0050661) |
0.0 | 1.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.8 | GO:0097109 | acetylcholine receptor binding(GO:0033130) neuroligin family protein binding(GO:0097109) |
0.0 | 0.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.2 | GO:0030614 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
0.0 | 0.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.0 | 0.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.2 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.0 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.6 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.2 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 1.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.6 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.6 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.1 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.5 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.7 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.6 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 1.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 0.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 1.3 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.0 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.2 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 1.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 2.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 6.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 3.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 5.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 5.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 3.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 5.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 2.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 2.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 3.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 2.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 3.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 1.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 2.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 2.3 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 7.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 1.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.3 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.7 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 1.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 1.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 2.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.7 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 1.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 1.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 5.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 9.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 2.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 3.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 4.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 6.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 4.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 2.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 2.0 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 1.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 3.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 2.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 4.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 1.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 1.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 3.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 2.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 2.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 2.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.6 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 1.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 1.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 1.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 1.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 2.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 1.0 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.6 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.4 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.0 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 2.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 1.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 1.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 2.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 3.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.4 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 1.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 1.0 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.2 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 1.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 2.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 6.4 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 2.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 1.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.8 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 1.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 1.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.7 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.6 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |